Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9
IntroductionHepatocellular carcinoma (HCC) is the most prevalent liver cancer and a leading cause of cancer-related deaths worldwide. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) plays a critical role in RNA metabolism, including alternative splicing, which is linked to cancer progression. O...
Saved in:
Main Authors: | Qi Ouyang, Wenhui He, Yiping Guo, Lin Li, Ying Mao, Xiang Li, Shuanglin Xiang, Xiang Hu, Jun He |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1517459/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HnRNPM modulates alternative splicing in germ cells by recruiting PTBP1
by: Peng Lv, et al.
Published: (2025-01-01) -
hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
by: Guoguo Jin, et al.
Published: (2025-01-01) -
AMPK: An energy sensor for non-small cell lung cancer progression and treatment
by: Zhi-Ting Zhong, et al.
Published: (2025-02-01) -
Evolutionarily Developed Alternatively Spliced Exons Containing Translation Initiation Sites
by: Jun-ichi Takeda, et al.
Published: (2024-12-01) -
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
by: Xuemei Lv, et al.
Published: (2025-01-01)